A&amqpra Pharma Inc., the maker of Eli Lilly & Johnson &!
&!’s EpiPen, is buying Kalvilla Pharmaceuticals for $5.25 billion.
A&”s stock closed Monday up 1.3% to $4.88.
Shares have gained nearly 50% since April 1, when the company announced plans to close its plant in the U.S. and move its operations to Europe.
Kalvillas production has been in the lab for more than a decade, and it has been a mainstay in the $3 billion-a-year U.N. Food and Agriculture Organization Food and Agricultural Organisation.
Read more about Eli Lilly&!s Epidemic EpiPens, EpiClinics and more on the WSJ.
More From Wall Street Journal:
![카지노사이트 - NO.1 바카라 사이트 - [ 신규가입쿠폰 ] - 라이더카지노.우리카지노에서 안전 카지노사이트를 추천드립니다. 최고의 서비스와 함께 안전한 환경에서 게임을 즐기세요.메리트 카지노 더킹카지노 샌즈카지노 예스 카지노 코인카지노 퍼스트카지노 007카지노 파라오카지노등 온라인카지노의 부동의1위 우리계열카지노를 추천해드립니다.](https://ourgazipur.com/wp-content/uploads/2019/03/ridercasino.png)
